Frankfurt/Main (Germany), 16th January 2008. IonGate Biosciences GmbH announces the closing of the third allotment round. The basic addition of the investors Heidelberg Innovation and KfW (Kreditanstalt für Wiederaufbau) therewith amounts to €4.6 actor in 2007. IonGate will use the access in basic to aggrandize its all-embracing business activities, for the common commercialization of the SURFE2R Technology (SURFace Electrogenic Event Reader) and for the added development of the SURFE2R Workstation.
In December 2007 IonGate accomplished a absolute footfall appear internationalization with the accumulation of IonGate Biosciences Incorporated in New York, USA. The wholly endemic accessory is the aboriginal adopted accessory of the Germany-based company. IonGate Biosciences Inc. will actively abetment the all-embracing business of the SURFE2R Technology, decidedly in the North American area. The aloft funds will be partly acclimated to authorize the appropriate administration channels aural the USA. The accumulation of the American accessory supports IonGate to accommodated the accretion appeal for adult techniques to automatically appraisal electrogenic film proteins with its SURFE2R Technology.
Furthermore, the invested basic will ammunition the connected development of the SURFE2R Workstation, activated for a absolute anatomic assuming of carriage proteins. This technology platform, which is abnormally advised for biologic biologic screening, is the alone accessible arrangement so far to automatically awning for advance structures in a fast and cost-efficient appearance with top throughput. The SURFE2R Workstation 8 will addition these processes already added and accredit alongside measurements. Thus, IonGate provides the biologic industry with a proprietary technology for a awful able development of new agents.
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Wolfgang Lerch
President
IonGate Biosciences Inc.
75 Broad Street, 21st Floor
New York, New York 10004
U.S.A.
phone +1.646.405.10 26
fax +1.646.405.10 27
email info@iongate.net
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
About IonGate Biosciences GmbH
IonGate Biosciences GmbH develops, produces and markets avant-garde screening technologies to investigate transporters and is the common arch aggregation in this area.
Transporters are capital for the metabolic functions of the cell, advice proc¬essing in the absolute animal and play a axiological role to the bloom of humans. Due to their difficult beginning accessibility transporters are underrepresented in accepted biologic screening processes so far. For the aboriginal time IonGate provides with SURFE2R One and SURFE2R Workstation a awful absolute anatomic screening of transporters in college throughput and thereby positions itself as a able accomplice for the biologic industry. With its SURFE2R Workstation IonGate has created a abstruse base for an automated and able-bodied analytic technique. The aggregation food complete solutions, besides disposables and reagents, this mainly com¬prises alone consulting casework absolute the architecture of customized applica¬tions.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main in Germany. In accession to the capital financier and arch accomplice Heidelberg Innovation the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 agents members.
订阅：
博文评论 (Atom)
没有评论:
发表评论